Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ISSN Print: 2278-1668, Online: 2278-0513
ARTICLE
Year: 2015   |   Volume: 4   |   Issue: 1   |   Page: 108-109     View issue

Role of anti-angiopoietin therapy with trebananib for recurrent epithelial ovarian cancer


, , ,
Cite this article
Vancouver
Kapoor A, Beniwal S, Dutta S, Kumar H. Role of anti-angiopoietin therapy with trebananib for recurrent epithelial ovarian cancer. Clin Cancer Investig J. 2015;4(1):108-9. https://doi.org/10.4103/2278-0513.149066
APA
Kapoor, A., Beniwal, S., Dutta, S., & Kumar, H. (2015). Role of anti-angiopoietin therapy with trebananib for recurrent epithelial ovarian cancer. Clinical Cancer Investigation Journal, 4(1), 108-109. https://doi.org/10.4103/2278-0513.149066

© Clinical Cancer Investigation Journal
Online since 01 December, 2011
Creative Commons License 
ISSN Print: 2278-1668, Online: 2278-0513